Scientists have identified a gene linked to the most common type of kidney cancer in children, and expressed hope this might help doctors determine which young patients are most at risk of dying.
Writing on Thursday in the journal Science, Massachusetts General Hospital researchers said about 30 percent of cases of the cancer called Wilms tumor involve mutations in a gene called WTX located on the sex-determining X chromosome.
About 90 percent of childhood kidney cancer cases are Wilms tumor. It occurs in roughly one in 10,000 children worldwide. It is treated with surgery and chemotherapy, with about 80 percent of patients surviving. It usually appears by age 5.
The disease also is called nephroblastoma.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the U.S. Food and Drug Administration (FDA) has accepted the file and granted priority review status to the Company's New Drug Application (NDA) for the investigational drug Torisel(TM) (temsirolimus). Wyeth Pharmaceuticals is seeking an indication for Torisel for the treatment of advanced renal cell carcinoma (RCC). A priority designation can be given to an NDA for a drug that, if approved, would be a significant improvement compared with existing treatments.